托法替尼治疗顽固性斑秃

Q2 Medicine International Journal of Trichology Pub Date : 2022-03-01 DOI:10.4103/ijt.ijt_128_21

G. Avhad

{"title":"托法替尼治疗顽固性斑秃","authors":"G. Avhad","doi":"10.4103/ijt.ijt_128_21","DOIUrl":null,"url":null,"abstract":"The activity of tofacitinib for Alopecia areata (AA) has been reported but mainly from the western countries. We report the case of a young female Indian patient with AA unresponsive to therapy. Improvements in terms of hair regrowth were observed within 2 months of treatment with oral tofacitinib 5 mg BID tablets. The effectiveness of tofacitinib in hair regrowth was maintained till 5-month follow-up period. There were no side effects reported and the treatment with tofacitinib was well-tolerated.","PeriodicalId":14417,"journal":{"name":"International Journal of Trichology","volume":"14 1","pages":"60 - 61"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Treatment of Resistant Alopecia areata with Tofacitinib\",\"authors\":\"G. Avhad\",\"doi\":\"10.4103/ijt.ijt_128_21\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The activity of tofacitinib for Alopecia areata (AA) has been reported but mainly from the western countries. We report the case of a young female Indian patient with AA unresponsive to therapy. Improvements in terms of hair regrowth were observed within 2 months of treatment with oral tofacitinib 5 mg BID tablets. The effectiveness of tofacitinib in hair regrowth was maintained till 5-month follow-up period. There were no side effects reported and the treatment with tofacitinib was well-tolerated.\",\"PeriodicalId\":14417,\"journal\":{\"name\":\"International Journal of Trichology\",\"volume\":\"14 1\",\"pages\":\"60 - 61\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Trichology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/ijt.ijt_128_21\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Trichology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijt.ijt_128_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

托法替尼治疗斑秃（AA）的活性已有报道，但主要来自西方国家。我们报告一例年轻的印度女性AA患者对治疗无反应。口服托法替尼5 mg BID片剂治疗后2个月内，观察到头发再生的改善。托法替尼对头发再生的有效性一直保持到5个月的随访期。没有副作用报告，托法替尼的治疗耐受性良好。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Treatment of Resistant Alopecia areata with Tofacitinib

The activity of tofacitinib for Alopecia areata (AA) has been reported but mainly from the western countries. We report the case of a young female Indian patient with AA unresponsive to therapy. Improvements in terms of hair regrowth were observed within 2 months of treatment with oral tofacitinib 5 mg BID tablets. The effectiveness of tofacitinib in hair regrowth was maintained till 5-month follow-up period. There were no side effects reported and the treatment with tofacitinib was well-tolerated.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

International Journal of Trichology Medicine-Dermatology

CiteScore

1.50

自引率

0.00%

发文量